A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This is a multicenter, open-label, Phase Ib clinical trial designed to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of multiple doses of the humanized monoclonal antibody EA5 in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
Epistemonikos ID: 1e19e33a3c2c3723558fcd73cba15eb267e667c8
First added on: Dec 02, 2025